Legal Representation
Attorney
Christina M. Licursi
USPTO Deadlines
Next Deadline
88 days remaining
NOA E-Mailed - SOU Required
Due Date
April 21, 2026
Extension Available
Until October 21, 2026
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 21, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 26, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 26, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 20, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 25, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 24, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 24, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 24, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 10, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 10, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 10, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 9, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 30, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 29, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jan 29, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of human diseases and disorders; pharmaceutical preparations for use in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases
Class 040
Custom manufacture of anelloviruses
Additional Information
Design Mark
The mark consists of the stylized wording RINGTX.
Pseudo Mark
RING TX
Classification
International Classes
005
040